Low dose Omacor® (1 g/day) did not influence plasma IL-6 concentration in patients studied following myocardial infarction [31], while others reported a lack of effect of Omacor® on sCD40L and MMP-9 concentrations [32]. This evidence concerns the gene CD40LG and myocardial infarction.